Skin tests for diagnostics of allergic immediate-type reactions;Hauttests zur diagnostik von allergischen soforttypreaktionen

Allergologie

Volumn 34, Issue 4, 2011, Pages 212-228

  Ruëff, Franziska ^a   Bergmann, K C ^b   Brockow, K ^c   Fuchs, T ^d   Grubl A ^e   Jung, K ^f   Klimek, L ^g   Musken H ^h   Pfaar, O ^g   Przybilla, B ^a   Sitter, H ⁱ   Wehrmann, W ^j  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^e Klinikum Schwabing   (Germany)

^f Praxis fur Dermatologie und Immunologie   (Germany)

^g ZENTRUM FÜR RHINOLOGIE UND ALLERGOLOGIE   (Germany)

^h Praxis F Inn Med Pneumologie Allergologie Umweltmedizin Sozialmedizin   (Georgia)

ⁱ PHILIPPS UNIVERSITY MARBURG   (Germany)

^j Praxis für Dermatologie und Allergologie   (Germany)

more..

Author keywords

Allergen; Allergic immediate type reaction; Allergy; Diagnostics; Guideline; Intradermal test; Prick test; Prick to prick test; Rub test; Scratch test; Specific IgE; Type I reaction

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ALLERGIC REACTION; ANAPHYLAXIS; ASTHMA; DIAGNOSTIC TEST; DISEASE SEVERITY; DRUG HALF LIFE; ERYTHEMA; FOREARM; HIGH RISK PATIENT; HUMAN; INTRACUTANEOUS TEST; PREGNANCY; PRICK TEST; REVIEW; SKIN DISEASE; SKIN SENSITIZATION; SKIN TEST; TREATMENT CONTRAINDICATION; URTICARIA;

EID: 79955707320     PISSN: 03445062     EISSN: None     Source Type: Journal    
DOI: 10.5414/alp34212     Document Type: Review

References (85)

1. Abramowitz PW, Perez MM, Johnson CE, McLean JA. Effect of theophylline, terbutaline, and their combination on the immediate hypersensitivity skin-test reaction. J Allergy Clin Immunol. 1980; 66: 123-128. (Evidenzlevel 1b)
2. Adinoff AD, Rosloniec DM, McCall LL, Nelson HS. A comparison of six epicutaneous devices in the performance of immediate hypersensitivity skin testing. J Allergy Clin Immunol. 1989; 84: 168-174. (Evidenzlevel 2b)
3. Allert M-H, Enzmann H. Schmerzloser Pricktest durch die Verwendung von EMLA? Allergologie. 1995; 18: 429-432. (Evidenzlevel 3)
4. Bergmann K-C, Müsken H. Kutane Tests. In: Przybilla B, Bergmann K-C, Ring J (Hrsg). Praktische allergologische Diagnostik. Darmstadt: Steinkopff; 2000. p. 9-22. (Evidenzlevel 4)
5. Berkowitz RB, Tinkelman DG, Lutz C, Crummie A, Smith K. Evaluation of the Multi-Test device for immediate hypersensitivity skin testing. J Allergy Clin Immunol. 1992; 90: 979-985. (Evidenzlevel 2b)
6. Bernstein DI, Wanner M, Borish L, Liss GM, Immunotherapy Committee, American Academy of Allergy, Asthma and Immunology. Twelve-year survey of fatal reactions to allergen injections and skin testing: 1990 - 2001. J Allergy Clin Immunol. 2004; 113: 1129-1136. (Evidenzlevel 4)
7. Bernstein IL, Li JT, Bernstein DI, Hamilton R, Spector SL, Tan R, Sicherer S, Golden DB, Khan DA, Nicklas RA, Portnoy JM, Blessing-Moore J, Cox L, Lang DM, Oppenheimer J, Randolph CC, Schuller DE, Tilles SA, Wallace DV, Levetin E, Weber R, American Academy of Allergy Asthma and Immunology, American College of Allergy Asthma and Immunology. Allergy diagnostic testing: an updated practice parameter. Ann Allergy Asthma Immunol. 2008; 100 (Suppl 3): S1-S148. (Evidenzlevel 4)
8. Bonnekoh B, Merk HF. Safety of latex prick skin testing in allergic patients. JAMA. 1992; 267: 2603-2604. (Evidenzlevel 4)
9. Bousquet J, Michel F-B. Precision of prick and puncture tests. J Allergy Clin Immunol. 1992; 90: 870-872. (Evidenzlevel 4)
10. Brockow K, Romano A, Blanca M, Ring J, Pichler W, Demoly P. General considerations for skin test procedures in the diagnosis of drug hypersensitivity. Allergy. 2002; 57: 45-51. (Evidenzlevel 4)
11. Cantani A, Micera M. The prick by prick test is safe and reliable in 58 children with atopic dermatitis and food allergy. Eur Rev Med Pharmacol Sci. 2006; 10: 115-120. (Evidenzlevel 3)
12. Carr WW, Martin B, Howard RS, Cox L, Borish L, Immunotherapy Committee of the American Academy of Allergy, Asthma and Immunology. Comparison of test devices for skin prick testing. J Allergy Clin Immunol. 2005; 116: 341-346. (Evidenzlevel 2b)
13. Chanal I, Horst M, Segalen C, Dreborg S, Michel FB, Bousquet J. Comparison between modified skin prick test with standardized allergen extracts and Phazet. J Allergy Clin Immunol. 1988; 82: 878-881. (Evidenzlevel 3)
14. Christensen M, Moelby L, Svendsen F. Reliability of skin prick tests during terfenadine treatment in adults with pollen rhinitis. Allergy. 1994; 49: 702-706. (Evidenzlevel 1b)
15. Corder WT, Wilson NW. Comparison of three methods of using the DermaPIK with the standard prick method for epicutaneous skin testing. Ann Allergy Asthma Immunol. 1995; 75: 434-438. (Evidenzlevel 3)
16. Cuhadaroglu C, Erelel M, Kiyan E, Ece T, Erkan F. Role of zafirlukast on skin prick test. Allergol Immunopathol (Madr). 2001; 29: 66-68. (Evidenzlevel 2b)
17. Demoly P, Bousquet J, Manderscheid J-C, Dreborg S, Dhivert H, Michel F-B. Precision of skin prick and puncture tests with nine methods. J Allergy Clin Immunol. 1991; 88: 758-762. (Evidenzlevel 2a)
18. Demoly P, Piette V, Bousquet J. In vivo methods for study of allergy. In: Adkinson NF Jr,Yunginger JW, BusseWW, Bochner BS, Holgate ST, Simons FER (eds). Middletons Allergy - Principles and Practice. 6th edition. Philadelphia: Mosby; 2003. p. 430-439. (Evidenzlevel 4)
19. Des Roches A, Paradis L, Bougeard YH, Godard P, Bousquet J, Chanez P. Long-term oral corticosteroid therapy does not alter the results of immediate- type allergy skin prick tests. J Allergy Clin Immunol. 1996; 98: 522-527. (Evidenzlevel 2b)
20. Devenney I, Fälth-Magnusson K. Skin prick tests may give generalized allergic reactions in infants. Ann Allergy Asthma Immunol. 2000; 85: 457-460. (Evidenzlevel 3)
21. Dreborg S. The risk of general reactions to skin prick testing (SPT). Allergy. 1996; 51: 60-61. (Evidenzlevel 4)
22. Dreborg S. Histamine reactivity of the skin. Allergy. 2001; 56: 359-364. (Evidenzlevel 4)
23. Dreborg S, Frew A, EAACI Subcommittee on Skin Tests. Position paper: Allergen standardization and skin tests. Allergy. 1993; k48 (Suppl): 48-82. (Evidenzlevel 4)
24. Dreborg S, Holgersson M, Nilsson G, Zetterström O. Dose response relationship of allergen, histamine, and histamine releasers in skin prick test and precision of the skin prick test method. Allergy. 1987; 42: 117-125. (Evidenzlevel 3)
25. Dundas I, Chan E, McKenzie SA. Faster, simpler skin-prick testing. J Paediatr Child Health. 2005; 41: 695-696. (Evidenzlevel 2b)
26. Fisher MM, Bowey CJ. Intradermal compared with prick testing in the diagnosis of anaesthetic allergy. Br J Anaesth. 1997; 79: 59-63. (Evidenzlevel 3)
27. Fritsché R. Animal models in food allergy: assessment of allergenicity and preventive activity of infant formulas. Toxicol Lett. 2003; 140-141: 303-309. (Evidenzlevel 4)
28. Goldberg A,Confino-Cohen R. Timing of venom skin tests and IgE determinations after insect sting anaphylaxis. J Allergy Clin Immunol. 1997; 100: 182-184. (Evidenzlevel 3)
29. Gronemeyer W, Debelic M. Der sogenannte "Reibtest", seine Anwendung und klinische Bedeutung. Dermatologica. 1967; 134: 208-218. (Evidenzlevel 4)
30. Heinzerling L, Frew AJ, Bindslev-Jensen C, Bonini S, Bousquet J, Bresciani M, Carlsen KH, van Cauwenberge P, Darsow U, Fokkens WJ, Haahtela T, van Hoecke H, Jessberger B, Kowalski ML, Kopp T, Lahoz CN, Lodrup Carlsen KC, Papadopoulos NG, Ring J, Schmid-Grendelmeier P, Vignola AM, Wohrl S, Zuberbier T. Standard skin prick testing and sensitization to inhalant allergens across Europe - a survey from the GALEN Network. Allergy. 2005; 60: 1287-1300. (Evidenzlevel 2a)
31. Henzgen M, Ballmer-Weber B, Erdmann S, Fuchs T, Kleine-Tebbe J, Lepp U, Niggemann B, Raithel M, Reese I, Saloga J, Vieths S, Zuberbier T, Werfel T. Hauttestungen mit Nahrungsmittelallergenen. Allergo J. 2008; 17: 401-406. (Evidenzlevel 4)
32. Hill SL 3rd, Krouse JH. The effects of montelukast on intradermal wheal and flare. Otolaryngol Head Neck Surg. 2003; 129: 199-203. (Evidenzlevel 1b)
33. Hutin Y, Hauri A, Chiarello L, Catlin M, Stilwell B, Ghebrehiwet T, Garner J, Injection Safety Best Practices Development Group. Best infection control practices for intradermal, subcutaneous, and intramuscular needle injections. Bull World Health Organ. 2003; 81: 491-500. (Evidenzlevel 4)
34. Indrajana T, Spieksma FT, Voorhorst R. Comparative study of the intracutaneous, scratch and prick tests in allergy. Ann Allergy. 1971; 29: 639-650. (Evidenzlevel 3)
35. Jeep S, Reiprich G, Kunkel G. Yellow jacket allergy. Comparison of skin prick tests and intradermal tests with three different yellow jacket venom extracts. Allergy. 1992; 47: 35-40. (Evidenzlevel 3)
36. Kaplan AP, Anderson JA, Valentine MD, Lockey RF, Pierson WE, Zweiman B, Kaliner MA, Lichtenstein LM, Lieberman PL, Settipane GA, Sheffer AL, Yunginger JW. Beta-adrenergic blockers, immunotherapy, and skin testing. American Academy of Allergy and Immunology. J Allergy Clin Immunol. 1989; 84: 129-130. (Evidenzlevel 4)
37. Kelso JM. Application of topical corticosteroids to sites of positive immediate-type allergy skin tests to relieve itching: results of a double-blind, placebo- controlled trial. Ann Allergy Asthma Immunol. 2007; 98: 182-184. (Evidenzlevel 1b)
38. Kemeny DM, Lambourn EM, Patel S, Lessof MH. Comparison of a new type of skin test (Phazet) with existing skin test methods and the radioallergosorbent test (RAST). Clin Exp Allergy. 1989; 19: 613-617. (Evidenzlevel 2b)
39. King MJ, Lockey RF. Allergen prick-puncture skin testing in the elderly. Immunopharmacol Immunotoxicol. 2000; 22: 253-266. (Evidenzlevel 4)
40. Klimek L, Bachert C, Schlenter W. Die nasale Provokationstestung. Allergo J. 2001; 10: 396-405. (Evidenzlevel 4)
41. Koepke JW, Reller LB, Masters HA, Selner JC. Viral contamination of intradermal skin test syringes. Ann Allergy. 1985; 55: 776-778. (Evidenzlevel 4)
42. Koller DY, Pirker C, Jarisch R, Götz M. Influence of the histamine control on skin reactivity in skin testing. Allergy. 1992; 47: 58-59. (Evidenzlevel 3)
43. Kunz R, Ollenschlager G, Raspe H, Jonitz G, Donner-Banzhoff N. Evidenzbasierte Medizin in Klinik und Praxis. Köln: Deutscher Ärzte-Verlag; 2007. (Evidenzlevel 4)
44. Lockey RF, Benedict LM, Turkeltaub PC, Bukantz SC. Fatalities from immunotherapy and skin testing. J Allergy Clin Immunol. 1987; 79: 660-677. (Evidenzlevel 4)
45. Lüderitz-Püchel U, Keller-Stanislawski B, Haustein D. Neubewertung des Risikos von Test- und Therapieallergenen. Eine Analyse der UAW-Meldungen von 1991 bis 2000. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz. 2001; 44: 709-718. (Evidenzlevel 3)
46. Lutz CT, Bell CE, Wedner HJ, Krogstad DJ. Allergy testing of multiple patients should no longer be performed with a common syringe. N Engl J Med. 1984; 310: 1335-1337. (Evidenzlevel 4)
47. Malling H-J. Methods of skin testing. Allergy. 1993; 48 (Suppl 14): 55-56. (Evidenzlevel 4)
48. Malling H-J, Weeke B. Position paper: Immunotherapy. Allergy. 1993; 48 (Suppl 14): 9-35. (Evidenzlevel 4)
49. Maurer T. Guinea pigs in hypersensitivity testing. Methods. 2007; 41: 48-53. (Evidenzlevel 4)
50. Mazer BD, Al-Tamemi S, Yu JW, Hamid Q. Immune supplementation and immune modulation with intravenous immunoglobulin. J Allergy Clin Immunol. 2005; 116: 941-944. (Evidenzlevel 4)
51. McCann WA, Ownby DR. The reproducibility of the allergy skin test scoring and interpretation by board-certified/board-eligible allergists. Ann Allergy Asthma Immunol. 2002; 89: 368-371. (Evidenzlevel 3)
52. McKay SP, Meslemani D, Stachler RJ, Krouse JH. Intradermal positivity after negative prick testing for inhalants. Otolaryngol Head Neck Surg. 2006; 135: 232-235. (Evidenzlevel 3)
53. Ménardo JL, Bousquet J, Rodière M, Astruc J, Michel FB. Skin test reactivity in infancy. J Allergy Clin Immunol. 1985; 75: 646-651. (Evidenzlevel 3)
54. Munro CS, Higgins EM, Marks JM, Daly BM, Friedmann PS, Shuster S. Cyclosporin Ain atopic dermatitis: therapeutic response is dissociated from effects on allergic reactions. Br J Dermatol. 1991; 124: 43-48. (Evidenzlevel 3)
55. Nelson HS, Knoetzer J, Bucher B. Effect of distance between sites and region of the body on results of skin prick tests. J Allergy Clin Immunol. 1996; 97: 596-601. (Evidenzlevel 2b)
56. Nelson HS, Rosloniec DM, McCall LI, Ikle D. Comparative performance of five commercial prick skin test devices. J Allergy Clin Immunol. 1993; 92: 750-756. (Evidenzlevel 2b)
57. Niemeijer NR, Kauffman HF, van Hove W, Dubois AE, de Monchy JG. Effect of dilution, temperature, and preservatives on the long-term stability of standardized inhalant allergen extracts. Ann Allergy Asthma Immunol. 1996; 76: 535-540. (Evidenzlevel 2b)
58. Norman PS. In vivo methods of study of allergy: skin and mucosal technique and interpretation. In: Middleton E Jr, Ellis EF, Reed CE (eds). Allergy: principles and practice. 2nd edition. St. Louis: Mosby; 1982. p. 295-392. (Evidenzlevel 4)
59. Novembre E, Bernardini R, Bertini G, Massai G, Vierucci A. Skin-prick-test-induced anaphylaxis. Allergy. 1995; 50: 511-513. (Evidenzlevel 4)
60. Osterballe M, Scheller R, Stahl Skov P, Andersen KE, Bindslev-Jensen C. Diagnostic value of scratch-chamber test, skin prick test, histamine release and specific IgE in birch-allergic patients with oral allergy syndrome to apple. Allergy. 2003; 58: 950-953. (Evidenzlevel 2b)
61. Osterballe O,Weeke B. Anew lancet for skin prick testing. Allergy. 1979; 34: 209-212. (Evidenzlevel 2b)
62. Ownby DR, Anderson JA. An improved skin-test procedure for young children. J Allergy Clin Immunol. 1982; 69: 533-535. (Evidenzlevel 2b)
63. Petersen LJ, Skov PS. The effect of salmeterol and salbutamol on mediator release and skin responses in immediate and late phase allergic cutaneous reactions. Inflamm Res. 1999; 48: 527-532. (Evidenzlevel 2b)
64. Petersen LJ, Skov PS. Effect of terbutaline and bambuterol on immediate-type allergic skin responses and mediator release in human skin. Inflamm Res. 2003; 52: 372-377. (Evidenzlevel 1b)
65. Piette V, Bourret E, Bousquet J, Demoly P. Prick tests to aeroallergens: is it possible simply to wipe the device between tests? Allergy. 2002; 57: 940-942. (Evidenzlevel 2a)
66. Pipkorn U, Andersson M. Topical dermal anaesthesia inhibits the flare but not the wheal response to allergen and histamine in the skin prick test. Clin Allergy. 1987; 17: 307-311. (Evidenzlevel 2b)
67. Pipkorn U, Hammarlund A, Enerbäck L. Prolonged treatment with topical glucocorticoids results in an inhibition of the allergen-induced wheal-and- flare response and a reduction in skin mast cell numbers and histamine content. Clin Exp Allergy. 1989; 19: 19-25. (Evidenzlevel 1b)
68. Rancé F, Juchet A, Brémont F, Dutau G. Correlations between skin prick tests using commercial extracts and fresh foods, specific IgE, and food challenges. Allergy. 1997; 52: 1031-1035. (Evidenzlevel 4)
69. Rasp G. Pricktest: Nadel oder Lanzette? Allergologie. 1991; 12: 480-482. (Evidenzlevel 3)
70. Reid MJ, Lockey RF, Turkeltaub PC, Platts-Mills TA. Survey of fatalities from skin testing and immunotherapy 1985 - 1989. J Allergy Clin Immunol. 1993; 92: 6-15. (Evidenzlevel 3)
71. Renz H, Becker W-M, Bufe A, Kleine-Tebbe J, Raulf-Heimsoth M, Saloga J, Werfel T, Worm M. In-vitro-Allergiediagnostik. Gemeinsames Positionspapier der DGAKI und der DDG. Allergo J. 2002; 11: 492-506. (Evidenzlevel 4)
72. Ring J. Angewandte Allergologie. München: MMV; 1992. (Evidenzlevel 4)
73. Ring J, Brockow K, Duda D, Eschenhagen T, Fuchs T, Huttegger I, Kapp A, Klimek L, Müller U, Niggemann B, Pfaar O, Przybilla B, Rebien W, Rietschel E, Ruëff F, Schnadt S, Tryba M,Worm M, Sitter H, Schultze-Werninghaus G. Akuttherapie anaphylaktischer Reaktionen. Leitlinie. Allergo J. 2007; 16: 420-434. (Evidenzlevel 4)
74. Rosen JP, Selcow JE, Mendelson LM, Grodofsky MP, Factor JM, Sampson HA. Skin testing with natural foods in patients suspected of having food allergies: is it a necessity? J Allergy Clin Immunol. 1994; 93: 1068-1070. (Evidenzlevel 3)
75. Scherer K, Grize L, Schindler C, Surber C, Bircher AJ. Reaction pattern to histamine and codeine in a human intradermal skin test model. Clin Exp Allergy. 2007; 37: 39-46. (Evidenzlevel 2b)
76. Schnuch A, Aberer W, Agathos M, Brasch J, Frosch PJ, Fuchs T, Richter G. Leitlinien der Deutschen Kontaktallergie-Gruppe (DKG) zur Durchführung des Epikutantests mit Kontaktallergenen. Hautarzt. 2001; 52: 864-866. (Evidenzlevel 4)
77. Simons FER, Gillespie GA, Simons KJ. Local anaesthetic creams and intradermal skin tests. Lancet. 1992; 339: 1351-1352. (Evidenzlevel 1b)
78. Skassa-Brociek W, Manderscheid J-C, Michel F-B, Bousquet J. Skin test reactivity to histamine from infancy to old age. J Allergy Clin Immunol. 1987; 80: 711-716. (Evidenzlevel 3)
79. Spector SL. Effect of a selective beta 2 adrenergic agonist and theophylline on skin test reactivity and cardiovascular parameters. J Allergy Clin Immunol. 1979; 64: 23-28. (Evidenzlevel 2b)
80. Stefanoff V. Non-fatal anaphylaxis caused by ampicillin scratch-test. Report of case. Int J Oral Maxillofac Surg. 1989; 18: 17. (Evidenzlevel 4)
81. Turkeltaub PC, Gergen PJ. The risk of adverse reactions from percutaneous prick-puncture allergen skin testing, venipuncture, and body measurements: data from the second National Health and Nutrition Examination Survey 1976 - 1980 (NHANES II). J Allergy Clin Immunol. 1989; 84: 886-890. (Evidenzlevel 3)
82. Van Metre TE, Adkinson NF, Kagey-Sobotka A, Marsh DG, Norman PS, Rosenberg Van Metre GL. How should we use skin testing to quantify IgE sensitivity. J Allergy Clin Immunol. 1990; 86: 583-586. (Evidenzlevel 4)
83. Wood RA, Phipatanakul W, Hamilton RG, Eggleston PA. A comparison of skin prick tests, intradermal skin tests, and RASTs in the diagnosis of cat allergy. J Allergy Clin Immunol. 1999; 103: 773-779. (Evidenzlevel 3)
84. Zachariae R, Jorgensen MM, Egekvist H, Bjerring P. Skin reactions to histamine of healthy subjects after hypnotically induced emotions of sadness, anger, and happiness. Allergy. 2001; 56: 734-740. (Evidenzlevel 2b)
85. Zarei M, Renner CF, Kaplan MS, Staveren AM, Lin CK, Razo E, Goldberg B. Optimal skin prick wheal size for diagnosis of cat allergy. Ann Allergy Asthma Immunol. 2004; 92: 604-610. (Evidenzlevel 2b)